Clinical Trial Update: Sotorasib in Combination With Trastuzumab Deruxtecan for the Treatment of Locally Advanced and Metastatic Non-small Cell Lung Cancer With a KRAS G12C Mutation [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update announces an ongoing Phase 1/2 study evaluating sotorasib in combination with trastuzumab deruxtecan for KRAS G12C-mutant locally adv…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Enhertu (trastuzumab deruxtecan)
• LUMAKRAS (sotorasib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Locally Advanced Lung Non-Small Cell Carcinoma, Metastatic Lung Non-Small Cell Carcinoma | Phase 1, Phase 2 | Status: RECRUITING